|
US6074650A
(en)
|
1985-06-24 |
2000-06-13 |
Hoechst Aktiengesellschaft |
Membrane anchor/active compound conjugate, its preparation and its uses
|
|
AU5186090A
(en)
|
1989-02-23 |
1990-09-26 |
Colorado State University Research Foundation |
Gnrh analogs for destroying gonadotrophs
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US6024957A
(en)
|
1993-06-02 |
2000-02-15 |
Research Corporation Technologies, Inc. |
Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
|
|
US6106834A
(en)
|
1993-06-02 |
2000-08-22 |
Research Corporation Technologies, Inc. |
Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
|
|
GB9323199D0
(en)
|
1993-11-10 |
1994-01-05 |
Falkenberg J H F |
Leukaemia treatment
|
|
US6759509B1
(en)
|
1996-11-05 |
2004-07-06 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
US20110045005A1
(en)
|
2001-10-19 |
2011-02-24 |
Craig Crowley |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
WO2003048327A2
(en)
|
2001-12-03 |
2003-06-12 |
Abgenix, Inc. |
Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
|
|
KR20060079232A
(ko)
*
|
2003-09-18 |
2006-07-05 |
노파르티스 아게 |
치료용 결합 분자
|
|
AU2005216251B2
(en)
|
2004-02-23 |
2011-03-10 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
EP1661584A1
(en)
|
2004-11-26 |
2006-05-31 |
Heinz Dr. Faulstich |
Use of conjugates of amatoxins and phallotoxins with macromolecules for cancer and inflammation therapy
|
|
US7947839B2
(en)
|
2004-12-01 |
2011-05-24 |
Genentech, Inc. |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
|
|
WO2007092196A2
(en)
|
2006-01-27 |
2007-08-16 |
Cellerant Therapeutics, Inc. |
Compositions and methods for treating myeloid proliferative disorders
|
|
CA2645347A1
(en)
|
2006-03-10 |
2007-09-20 |
Diatos |
Anticancer drugs conjugated to antibody via an enzyme cleavable linker
|
|
ATE521366T1
(de)
|
2006-05-27 |
2011-09-15 |
Faulstich Heinz Dr |
Anwendung von amatoxin-konjugaten und phallotoxin-konjugaten mit makromolekülen zur krebstherapie und therapie von entzündungen
|
|
HRP20140172T1
(hr)
|
2006-05-30 |
2014-03-28 |
Genentech, Inc. |
Protutijela i imunokonjugati kao i njihove uporabe
|
|
KR20090094814A
(ko)
*
|
2006-10-10 |
2009-09-08 |
스퀴코어 |
암의 치료 및 진단을 위한 조성물 및 방법
|
|
PL3255061T3
(pl)
*
|
2006-11-03 |
2021-12-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Selektywna deplecja immunologiczna niszy endogennych komórek macierzystych do wszczepienia
|
|
ES2523915T5
(es)
|
2006-12-01 |
2022-05-26 |
Seagen Inc |
Agentes de unión a la diana variantes y usos de los mismos
|
|
RU2583270C2
(ru)
*
|
2009-04-01 |
2016-05-10 |
Дженентек, Инк. |
АНТИТЕЛА К FcRH5, ИХ ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
|
EP2416805B1
(en)
*
|
2009-04-08 |
2013-07-24 |
Heinz Dr. Faulstich |
Amatoxin antibody conjugates for the treatment of cancer
|
|
EP3192529B1
(en)
|
2009-04-08 |
2020-03-25 |
Faulstich, Heinz, Dr. |
Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
|
|
NZ602932A
(en)
|
2010-04-15 |
2014-08-29 |
Seattle Genetics Inc |
Targeted pyrrolobenzodiazapine conjugates
|
|
ES2402254T3
(es)
|
2010-09-30 |
2013-04-30 |
Heidelberg Pharma Ag |
Conjugados de amatoxinas con ligadores mejorados
|
|
EP2497499A1
(en)
|
2011-03-10 |
2012-09-12 |
Heidelberg Pharma GmbH |
Amatoxin-conjugates with improved linkages
|
|
KR101976882B1
(ko)
*
|
2011-03-23 |
2019-05-09 |
프레드 헛친슨 켄서 리서치 센터 |
세포 면역요법용 방법 및 조성물
|
|
BR122020001787A8
(pt)
|
2011-05-08 |
2023-04-25 |
Legochem Biosciences Inc |
Conjugado de anticorpo-agente ativo, seus métodos de preparação, sua composição e seu uso
|
|
CA2850375C
(en)
|
2011-10-14 |
2019-07-02 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
US9388187B2
(en)
|
2011-10-14 |
2016-07-12 |
Medimmune Limited |
Pyrrolobenzodiazepines
|
|
WO2013093809A1
(en)
|
2011-12-23 |
2013-06-27 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
US9504756B2
(en)
|
2012-05-15 |
2016-11-29 |
Seattle Genetics, Inc. |
Self-stabilizing linker conjugates
|
|
EP2684865A1
(en)
|
2012-07-13 |
2014-01-15 |
Heidelberg Pharma GmbH |
Methods for synthesizing amatoxin building block and amatoxins
|
|
WO2014043403A1
(en)
|
2012-09-12 |
2014-03-20 |
Agensys, Inc. |
Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase
|
|
US9324898B2
(en)
*
|
2012-09-25 |
2016-04-26 |
Alliance For Sustainable Energy, Llc |
Varying cadmium telluride growth temperature during deposition to increase solar cell reliability
|
|
AU2013350802B2
(en)
*
|
2012-11-30 |
2016-07-14 |
Novartis Ag |
Methods for making conjugates from disulfide-containing proteins
|
|
WO2014134539A1
(en)
|
2013-02-28 |
2014-09-04 |
President And Fellows Of Harvard College |
Methods and compositions for mobilizing stem cells
|
|
EP2774624A1
(en)
|
2013-03-04 |
2014-09-10 |
Heidelberg Pharma GmbH |
Amatoxin derivatives
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
WO2014151030A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Novartis Ag |
Cell proliferation inhibitors and conjugates thereof
|
|
US9803002B2
(en)
|
2013-05-31 |
2017-10-31 |
Genentench, Inc. |
Anti-wall teichoic antibodies and conjugates
|
|
US11229711B2
(en)
|
2013-06-06 |
2022-01-25 |
Magenta Therapeutics, Inc. |
Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
US10071170B2
(en)
|
2013-06-24 |
2018-09-11 |
Ablbio |
Antibody-drug conjugate having improved stability and use thereof
|
|
FR3008408B1
(fr)
|
2013-07-11 |
2018-03-09 |
Mc Saf |
Nouveaux conjugues anticorps-medicament et leur utilisation en therapie
|
|
CN105377304B
(zh)
*
|
2014-03-10 |
2018-05-15 |
海德堡医药有限责任公司 |
鹅膏毒肽衍生物
|
|
JP6800021B2
(ja)
|
2014-06-02 |
2020-12-16 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
抗体−薬物コンジュゲート、それらの製造、及びそれらの治療用途
|
|
EP3174902B1
(en)
*
|
2014-08-01 |
2019-04-17 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
An anti-cd45rc antibody for use as drug
|
|
RU2715905C2
(ru)
|
2014-10-01 |
2020-03-04 |
МЕДИММЬЮН, ЭлЭлСи |
Способ конъюгации полипептида
|
|
US20190209704A1
(en)
|
2014-10-20 |
2019-07-11 |
Igenica Biotherapeutics, Inc. |
Novel antibody-drug conjugates and related compounds, compositions and methods of use
|
|
WO2016071856A1
(en)
*
|
2014-11-06 |
2016-05-12 |
Novartis Ag |
Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
|
|
EP3026060A1
(en)
*
|
2014-11-26 |
2016-06-01 |
Miltenyi Biotec GmbH |
Humanized antibody or fragment thereof specific for CD45R0
|
|
US9729129B2
(en)
*
|
2014-12-05 |
2017-08-08 |
Bhaskar Gopalan |
System and method for reducing metastability in CMOS flip-flops
|
|
US20160220687A1
(en)
|
2015-02-02 |
2016-08-04 |
National Guard Health Affairs |
Metalloproteinase-cleavable alpha-amanitin-dendrimer conjugates and method of treating cancer
|
|
PT3268047T
(pt)
|
2015-03-09 |
2023-12-05 |
Heidelberg Pharma Res Gmbh |
Conjugados amatoxina-anticorpo
|
|
WO2016164502A1
(en)
|
2015-04-06 |
2016-10-13 |
President And Fellows Of Harvard College |
Compositions and methods for non-myeloablative conditioning
|
|
EP3297684B1
(en)
|
2015-05-21 |
2020-12-23 |
Actinium Pharmaceuticals, Inc. |
Infusion administration of conjugated monoclonal antibodies
|
|
WO2017051249A1
(en)
|
2015-09-25 |
2017-03-30 |
Legochem Biosciences, Inc. |
Compositions and methods related to anti-cd19 antibody drug conjugates
|
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
|
JP2018536666A
(ja)
|
2015-11-27 |
2018-12-13 |
ハイデルベルク ファルマ リサーチ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
γ−アマニチンの誘導体
|
|
EP3222292A1
(en)
|
2016-03-03 |
2017-09-27 |
Heidelberg Pharma GmbH |
Amanitin conjugates
|
|
WO2017155937A1
(en)
|
2016-03-07 |
2017-09-14 |
Actinium Pharmaceuticals, Inc. |
Stabilized radiolabeled anti-cd45 immunoglobulin compositions
|
|
KR102295190B1
(ko)
|
2016-04-20 |
2021-08-30 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
아마니타 독소의 유도체 및 세포 결합 분자와의 그것의 결합
|
|
US10464969B2
(en)
|
2016-05-05 |
2019-11-05 |
Novartis Ag |
Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase
|
|
CA3022802A1
(en)
|
2016-05-27 |
2017-11-30 |
Actinium Pharmaceuticals, Inc. |
Low dose antibody-based methods for treating hematologic malignancies
|
|
EP3471771A4
(en)
|
2016-05-31 |
2020-04-15 |
Sorrento Therapeutics, Inc. |
ANTIBODY CONJUGATES HAVING AMATOXIN DERIVATIVES AS A MEDICINAL PRODUCT
|
|
US10111966B2
(en)
|
2016-06-17 |
2018-10-30 |
Magenta Therapeutics, Inc. |
Methods for the depletion of CD117+ cells
|
|
WO2018039810A1
(en)
|
2016-08-29 |
2018-03-08 |
Pdi Pharm Development International Ag |
Provision of a therapeutically active cell product
|
|
US10112266B2
(en)
*
|
2016-09-09 |
2018-10-30 |
Baltic Innovation Holding PRO, AS |
Pressed thermite rod for a self-contained portable cutting device
|
|
JP7360323B2
(ja)
*
|
2016-10-13 |
2023-10-12 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
骨髄非破壊前処理のための組成物および方法
|
|
PT3558390T
(pt)
|
2016-12-23 |
2024-10-29 |
Heidelberg Pharma Res Gmbh |
Conjugados amanitina anticorpo
|
|
US10576161B2
(en)
|
2017-01-20 |
2020-03-03 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of CD137+ cells
|
|
BR112019015342A2
(pt)
|
2017-01-30 |
2020-03-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Regime de condicionamento não genotóxico para o transplante de células-tronco
|
|
EP3661938B1
(en)
|
2017-08-07 |
2025-01-15 |
Heidelberg Pharma Research GmbH |
Novel method for synthesizing amanitins
|